Caricamento...
Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy
Coronavirus disease 2019 (COVID-19) may have a metabolic origin given strong links with risk factors such as lipids and glucose and co-morbidities such as obesity and type 2 diabetes mellitus. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein mediates viral cellular entr...
Salvato in:
| Pubblicato in: | Med Hypotheses |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier Ltd.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7430295/ https://ncbi.nlm.nih.gov/pubmed/33017906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.110197 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|